Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 2
2014 4
2015 7
2016 5
2017 5
2018 7
2019 4
2020 5
2021 5
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Heart and systemic sclerosis-findings from a national cohort study.
Guédon AF, Carrat F, Mouthon L, Launay D, Chaigne B, Pugnet G, Lega JC, Hot A, Cottin V, Agard C, Allanore Y, Fauchais AL, Jego P, Dhote R, Papo T, Chatelus E, Bonnotte B, Khan JE, Diot E, Bienvenu B, Magy-Bertrand N, Queyrel V, Le Quellec A, Kieffer P, Amoura Z, Harlé JR, Gaultier JB, Balquet MH, Wahl D, Lidove O, Fain O, Mékinian A, Hachulla E, Rivière S. Guédon AF, et al. Among authors: riviere s. Rheumatology (Oxford). 2023 Nov 7:kead599. doi: 10.1093/rheumatology/kead599. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37944039
[Misleading headache..].
Thietart S, Rivière S, Mekinian A, Fain O. Thietart S, et al. Among authors: riviere s. Rev Prat. 2017 Nov 20;67(9):987-990. Rev Prat. 2017. PMID: 30516909 French. No abstract available.
Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Senet P, Maillard H, Diot E, Lazareth I, Blaise S, Arnault JP, Pistorius MA, Boulon C, Cogrel O, Warzocha U, Rivière S, Malloizel-Delaunay J, Servettaz A, Sassolas B, Viguier M, Monfort JB, Janique S, Vicaut E; BRASS collaborators. Senet P, et al. Among authors: riviere s. Arthritis Rheumatol. 2023 Mar;75(3):459-467. doi: 10.1002/art.42342. Epub 2022 Dec 14. Arthritis Rheumatol. 2023. PMID: 36066501 Clinical Trial.
Overview of osteo-articular involvement in systemic sclerosis: Specific risk factors, clinico-sonographic evaluation, and comparison with healthy women from the French OFELY cohort.
Thietart S, Louati K, Gatfosse M, Sornay-Rendu E, Gaigneux E, Lemeunier L, Delmaire P, Riviere S, Mahevas T, Sellam J, Berenbaum F, Fain O, Roland C, Mekinian A. Thietart S, et al. Among authors: riviere s. Best Pract Res Clin Rheumatol. 2018 Aug;32(4):591-604. doi: 10.1016/j.berh.2019.01.008. Epub 2019 Feb 20. Best Pract Res Clin Rheumatol. 2018. PMID: 31174827 Review.
Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature.
Sanges S, Rivière S, Mekinian A, Martin T, Le Quellec A, Chatelus E, Lescoat A, Jego P, Cazalets C, Quéméneur T, Le Gouellec N, Senet P, Francès C, Deroux A, Imbert B, Fain O, Boukari L, Sené T, Deligny C, Mathian A, Agard C, Pugnet G, Speca S, Dubucquoi S, Hatron PY, Hachulla É, Launay D. Sanges S, et al. Among authors: riviere s. Autoimmun Rev. 2017 Apr;16(4):377-384. doi: 10.1016/j.autrev.2017.02.008. Epub 2017 Feb 13. Autoimmun Rev. 2017. PMID: 28232167 Review.
Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy.
Bennedjaï A, Bouheraoua N, Gatfossé M, Dupasquier-Fediaevsky L, Errera MH, Tazartes M, Borderie V, Hennocq Q, Dellal A, Riviere S, Heron E, Fain O, Mekinian A. Bennedjaï A, et al. Among authors: riviere s. Ocul Immunol Inflamm. 2022 Feb 17;30(2):500-505. doi: 10.1080/09273948.2020.1808688. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2022. PMID: 32965148
49 results